Clinical Trial Update: An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder

View source ↗

Summary

The observational trial of BOTOX for idiopathic overactive bladder–related urinary incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Urinary Incontinence, Urinary Bladder, Overactive | Status: COMPLETED